Substance P content of substantia nigra after chronic treatment with antischizophrenic drugs.
D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D003024:Clozapine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D008297:Male; D010868:Pimozide / Q000494:pharmacology; D051381:Rats; D013373:Substance P / Q000378:metabolism*; D013378:Substantia Nigra / Q000187:drug effects / Q000378:metabolism*; D013997:Time Factors
D014150:Antipsychotic Agents; D010868:Pimozide; D013373:Substance P; D003024:Clozapine; D006220:Haloperidol